Reaction of [(IPr)Cu-OtBu] (1) with pinB-SiMe(2)Ph (2) leads to the Cu-silyl complex [(IPr)Cu-SiMe(2)Ph] (3). Insertion of CO(2) into the Cu-Si bond of 3 is followed by transformation of the resulting silanecarboxy complex [(IPr)Cu-O(2)CSiMe(2)Ph] (4) to the silanolate complex [(IPr)Cu-OSiMe(2)Ph] (5) via extrusion of CO. As 5 reacts readily with 2 to regenerate 3, a catalytic CO(2) reduction to CO is feasible. The individual steps were studied by in situ(13)C NMR spectroscopy of a series of stoichiometric reactions. Complexes 3, 4, and 5 were isolated and fully characterized, including single-crystal X-ray diffraction studies. Interestingly, the catalytic reduction of CO(2) using silylborane 2 as a stoichiometric reducing agent leads not only to CO and pinB-O-SiMe(2)Ph but also to PhMe(2)Si-CO(2)-SiMe(2)Ph as an additional reduction product.
No takes yet. Share an insight, caveat, or question.
Kleeberg et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: